Standardized Cannabis sativa extract attenuates tau and stathmin gene expression in the melanoma cell line

Authors

1 Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

2 Applied Physiology Research Center, Cardiovascular Research Institute, Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Objective(s): Metastasis is the main cause of death in patients with melanoma. Cannabis-based medicines are effective adjunctive drugs in cancer patients. Tau and Stathmin proteins are the key proteins in cancer metastasis. Here we have investigated the effect of a standardized Cannabis sativa extract on cell migration and Tau and Stathmin gene expression in the melanoma cell line.
Materials and Methods: In the treatment group, melanoma (B1617) was treated 48 hr with various concentrations of standardized C. sativa extract. Cells with no treatment were considered as the control group, then study was followed by Quantitative RT-Real Time PCR assay. Relative gene expression was calculated by the ΔΔct method. Migration assay was used to evaluate cancer metastasis.
Results: Tau and stathmin gene expression was significantly decreased compared to the control group. Cell migration was also significantly reduced compared to controls. 
Conclusion: C. sativa decreased tau and stathmin gene expression and cancer metastasis.  The results may have some clinical relevance for the use of cannabis-based medicines in patients with metastatic melanoma.

Keywords


1. Damsky WE,  Rosenbaum LE, Bosenberg M. Decoding melanoma metastasis. Cancers (Basel) 2011; 3:126–163.

2. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. Cell migration: integrating signals from front to back.Science 2003; 302:1704–1709.

3. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights andevolving paradigms. Cell 2011, 147:275–292.

4. Yang ZL, Miao X, Xiong L, Zou Q, Yuan Y, Li J, et al. CFL1 and Arp3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinomas of gallbladder. Cancer Invest 2013; 31:132–139.

5. Byrne FL, Yang L, Phillips PA, Hansford LM, Fletcher JI, Ormandy CJ, et al. Kavallaris M: RNAi-mediated stathmin suppression reduceslung metastasis in an orthotopic neuroblastoma mouse model. Oncogene 2013; 10:1038.

6. Stevenson RP, Veltman D, Machesky LM. Actin-bundling proteins in cancer progression at a glance. J Cell Sci 2012; 125:1073–1079.

7. Riplinger SM, Wabnitz GH, Kirchgessner H, Jahraus B, Lasitschka F, Schulte B, et al. Metastasis of prostate cancer and melanoma cells in a preclinical in vivo mouse model is enhanced by L-plastin expression and phosphorylation. Mol Cancer 2014; 13:10.

8. Hayden JH, Bowser SS, Rieder CL. Kinetochores capture astral microtubules during chromosome attachment to the mitotic spindle: direct visualization in live newt lung cells. J Cell Biol 1990; 111:1039– 1045.

9. Zhai Y, Kronebusch PJ, Simon PM, Borisy GG. Microtubule dynamics at the G2/Mtransition: abrupt breakdown of cytoplasmic microtubules at nuclear envelope breakdown and implications for spindle morphogenesis. J Cell Biol 1996; 135: 201–214.

10. Andersen SSL. Spindle assembly and the art of regulating microtubule dynamics byMAPs and stathmin/Op18.Trends Cell Biol 2000; 10:261–267.

11. Cassimeris L, Spittle C. Regulation of microtubule-associated proteins. Int Rev Cytol 2001; 210:163–226.

12. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. A protein factor essential for microtubule assembly.Proc Natl Acad Sci U S A 1975; 72:1858–1868.

13. Goedert M. Tau protein and neurodegeneration. Semin Cell Dev Biol 2004; 15:45–49.

14. Knops J, Kosik KS, Lee G, Pardee JD, Cohen-Gould L, McConlogue L. Overexpression of tau in a nonneuronal cell induces long cellular processes. J Cell Biol 1991; 114:725–733.

15. Mistry SJ, Atweh GF. Stathmin inhibition enhances okadaic acid-induced mitotic arrest. A potential role for stathmin in mitotic exit. J Biol Chem 2001; 276: 1209–1215.

16. Mistry S, Atweh G. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy. Mt Sinai J Med 2002; 69:299–304.

17. Brattsand G, Roos G, Marklund U, Ueda H, Landberg G, Nånberg E, et al. Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein in normal and neoplastic cells. Leukemia 1993; 7:569–579.

18. Brattsand G. Correlation of oncoprotein 18/stathmin-expression in human breast cancer with establishedprognostic factors. Br J Cancer 2000; 83:311–318.

19. Adams R. Marihuana: Harvey lecture. Bull N Y Acad Med 1942; 18:705-730.

20. Sarfaraz S, Adhami VM, Syed DN, Afaq F, Mukhtar H. Cannabinoids for cancer treatment: progress and promise. Cancer Res 2008; 68:339–342.

21. Bosier B, Muccioli GG, Hermans E, Lambert DM. Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Biochem Pharmacol 2010; 80:1–12.

22. Hermanson D, Marnett L. Cannabinoids, endocanna-binoids, and cancer. Cancer Metastasis Rev 2011; 30:599–612.

23. Joseph J, Niggemann B, Zaenker K, Entschladen F. Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol Immunother 2004; 53:723–728.

24. Rouzier R, Rajan R, Wagner P, Hess KR, Gold DL, Stec J, et al. Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci U S A 2005; 102:8315-8320.

25. Matrone MA, Whipple RA, Thompson K, Cho EH, Vitolo MI, Balzer EM, et al. Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells. Oncogene 2010; 29:3217-3227.

26. Matrone MA, Whipple RA, Thompson K, Cho EH, Vitolo MI, Balzer EM, et al. Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells. Oncogene 2010; 29:3217-3227.

27. Schmitt S, Safferling K, Westphal K. Stathmin regulates keratinocyte proliferation  and  migration  during  cutaneous regeneration. PLoS One 2013; 8:750-775.

28. Hsu HP1, Li CF, Lee SW, Wu WR, Chen TJ, Chang KY, et al. Overexpression of stathmin 1 confers an  independent  prognostic  indicator  in nasopharyngeal carcinoma. Tumour Biol 2013; 2619-29.

29.  Wang R,  Dong K,  Lin f,  Wang X,  Gao P, Wei SH, et al. Inhibiting proliferation and enhancing chemosensitivity to taxanes in osteosarcoma cells by RNA interference-mediated downregulation of stathmin expression. Mol Med 2007; 13:567–575.

30. Velasco G ,  Hernández-Tiedra S,  Dávila D,  Lorente ar: The use of cannabinoids as anticancer agents. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2015; 259-266.

31. Cudaback E, Marrs W , Moeller T, Stella N. The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. PLoS One 2010; 5:e8702.

32.  Freimuth N, Ramer N, Hinz B. Antitumorigenic effects of cannabinoids beyond apoptosis J. Pharmacol Exp Ther  2010; 332:336–344.

33. Fogli S, Nieri P, Chicca A, Adinolfi B, Mariotti V, Iacopetti P, et al. Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism FEBS Lett 2006; 589:1733–1739.

34. Ramer R, Bublitz K, Freimuth N,  Merkord J, Rohde H,  Haustein H,  et al. Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1.FASEB J 2012; 26:1535–1548.